Literature DB >> 4558866

Passive immunization against the local Shwartzman reaction.

A I Braude, H Douglas.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4558866

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  30 in total

1.  Mechanisms of endotoxin tolerance. The role of the spleen.

Authors:  S E Greisman; E J Young; J B Workman; R M Ollodart; R B Hornick
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

2.  The nature of endotoxin tolerance.

Authors:  S E Greisman; R B Hornick
Journal:  Trans Am Clin Climatol Assoc       Date:  1975

Review 3.  Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock.

Authors:  J D Baumgartner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

4.  Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.

Authors:  M Trautmann; H Hahn
Journal:  Infection       Date:  1985 May-Jun       Impact factor: 3.553

5.  Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

Authors:  M I Marks; E J Ziegler; H Douglas; L B Corbeil; A I Braude
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  Human antiserum for prevention of the local shwartzman reaction and death from bacterial lipopolysaccharides.

Authors:  E J Ziegler; H Douglas; A I Braude
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

7.  Lipid A and anti-lipid A.

Authors:  I Mattsby-Baltzer; B Kaijser
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.

Authors:  B W Fenwick; J S Cullor; B I Osburn; H J Olander
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

9.  Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.

Authors:  R W Vreede; J Leuvenink; A S Bouter; E C Brouwer; J H Marcelis; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

10.  Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time.

Authors:  D E McCallus; N L Norcross
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.